You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • ANA-positive primary immune thrombocytopaenia: a different clinical entity with increased risk of connective tissue diseases

Article info

Article menu
Immunology and inflammation
Original research
ANA-positive primary immune thrombocytopaenia: a different clinical entity with increased risk of connective tissue diseases

Authors

  • Yuan Liu Department of Rheumatology and Clinical Immunology, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, ChinaSchool of Medicine, Xiamen University, Xiamen, China PubMed articlesGoogle scholar articles
  • Shiju Chen Department of Rheumatology and Clinical Immunology, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, ChinaSchool of Medicine, Xiamen University, Xiamen, China PubMed articlesGoogle scholar articles
  • Guomei Yang School of Medicine, Xiamen University, Xiamen, ChinaDepartment of Rheumatology, The Affiliated Hospital of Southwest Medical University, Luzhou, China PubMed articlesGoogle scholar articles
  • Bin Wang Department of Rheumatology and Clinical Immunology, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China PubMed articlesGoogle scholar articles
  • Jinying Lan Department of Rheumatology and Clinical Immunology, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, ChinaSchool of Medicine, Xiamen University, Xiamen, China PubMed articlesGoogle scholar articles
  • Fan Dai Department of Rheumatology and Clinical Immunology, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, ChinaSchool of Medicine, Xiamen University, Xiamen, China PubMed articlesGoogle scholar articles
  • Peishi Rao Department of Rheumatology and Clinical Immunology, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, ChinaSchool of Medicine, Xiamen University, Xiamen, China PubMed articlesGoogle scholar articles
  • Puqi Wu Department of Rheumatology and Clinical Immunology, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, ChinaSchool of Medicine, Xiamen University, Xiamen, China PubMed articlesGoogle scholar articles
  • Hongyan Qian Department of Rheumatology and Clinical Immunology, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, ChinaSchool of Medicine, Xiamen University, Xiamen, China PubMed articlesGoogle scholar articles
  • Guixiu Shi Department of Rheumatology and Clinical Immunology, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, ChinaSchool of Medicine, Xiamen University, Xiamen, China PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Guixiu Shi; gshi{at}xmu.edu.cn
View Full Text

Citation

Liu Y, Chen S, Yang G, et al
ANA-positive primary immune thrombocytopaenia: a different clinical entity with increased risk of connective tissue diseases
Lupus Science & Medicine 2021;8:e000523. doi: 10.1136/lupus-2021-000523

Publication history

  • Received May 27, 2021
  • Accepted September 16, 2021
  • First published October 5, 2021.
Online issue publication 
July 06, 2022

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.